Leukemia Inhibitory Factor - HIV-1 inhibitor

Drug Profile

Leukemia Inhibitory Factor - HIV-1 inhibitor

Alternative Names: HIV-1 inhibitor - Leukemia Inhibitory Factor; LIF - HIV-1 inhibitor

Latest Information Update: 04 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Childrens Memorial Hospital (Chicago)
  • Developer Childrens Memorial Hospital (Chicago); Invirion Corporation
  • Class Proteins
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 04 May 2007 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
  • 16 Oct 2001 Preclinical development for HIV infections prevention in USA (Unknown route)
  • 16 Oct 2001 A study has been added to the Viral infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top